Skip to content

Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria

Prevalence and Clinical Characteristics of Patients With Bronchiectasis With Comorbid Nontuberculous Mycobacteria Among Middle-aged and Old Women

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03594032
Enrollment
216
Registered
2018-07-20
Start date
2018-08-14
Completion date
2021-08-31
Last updated
2020-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis, Non-tuberculous Mycobacterial

Keywords

bronchiectasis, NTM infections, Middle-aged and old women

Brief summary

The purpose of this study is to Understand the prevalence of non-tuberculous mycobacterial(NTM) infections in the middle-aged and old women patients with bronchiectasis in Mainland China, and explore the characteristics of patients with bronchiectasis comorbid NTM.

Detailed description

The development of bronchiectasis is closely related to chronic infection of pathogenic microorganisms .Bronchiectasis and nontuberculous mycobacterial (NTM) infections are inextricably linked Pathophysiologically. But the incidence rate and characteristics of NTM infections among patients with bronchiectasis remains unclear in mainland China. In this study, we will collect data of participants about demographic ,co-morbidities ,spirometry, mMRC score ,exacerbation history, QOL-B questionnaire, aetiology, spirometry , HRCT(or CT) scan ,results of microbiology samples and treatments, collect three consecutive sputum(or induced sputum) samples to smear, bacteria culture, acid-fast stain, mycobacterium cultivation and identification, drug susceptibility testing of nontuberculous mycobacteria.To estimate the prevalance of non-tuberculous mycobacterial(NTM) infections in Middle-aged and old women patients with bronchiectasis in northern China. To analyze clinical manifestations and microbiological characteristics of patients with bronchiectasis comorbid NTM infections By 16SRNA and gene sequencing. In addition, A cross-sectional investigation about lung function and clinical data will be done among patients who have confirmed bronchiectasis with NTM from February 2017 to December 2020.

Interventions

None listed

Sponsors

Bin Cao
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Middle-aged and old women who are \> or = 50 years of age 2. Patients meet the criteria of bronchiectasis

Exclusion criteria

1. Cystic fibrosis 2. After organ transplantation 3. Activity tumor (malignant solid tumor and blood system tumor) 4. Pulmonary interstitial fibrosis with bronchus dilation 5. Allergic bronchopulmonary aspergillosis 6. Diffuse panbronchiolitis 7. Patients refused to sign the informed consent 8. Patients unable to return sputum specimens

Design outcomes

Primary

MeasureTime frameDescription
NTM infection rates24 months afer enrolled participantsNTM infection rates in Middle-aged and old women patients with bronchiectasis in northern China

Secondary

MeasureTime frameDescription
clinical characteristics of patients with bronchiectasis comorbid NTM infections24 months afer enrolled participantsclinical manifestations of patients with bronchiectasis comorbid NTM infections
microbiological characteristics of patients with bronchiectasis comorbid NTM infections24 months afer enrolled participantsmicrobiological characteristics of patients with bronchiectasis comorbid NTM
Drug resistance of NTM24 months afer enrolled participantsdrug susceptibility testing outcomes of nontuberculous mycobacteria from sputum samples

Countries

China

Contacts

Primary ContactHongjun Yin, MD
yhjh1101@163.com86 13621089726
Backup ContactBen Cao, MD
caobin_ben@163.com86-010-84206264

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026